Dual phase priming by IL-3 for leukotriene C4 generation in human basophils: Difference in characteristics between acute and late priming effects

Journal of Immunology

Volumn 164, Issue 6, 2000, Pages 3026-3034

  Miura, Katsushi ^a   MacGlashan Jr , Donald W ^a  

^a JOHNS HOPKINS ASTHMA AND ALLERGY CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; CALCIUM ION; COMPLEMENT COMPONENT C5A; CYCLOHEXIMIDE; HISTAMINE; INTERLEUKIN 3; LEUKOTRIENE C4; MITOGEN ACTIVATED PROTEIN KINASE; PHOSPHOLIPASE A2;

ARTICLE; BASOPHIL; CALCIUM CELL LEVEL; CONTROLLED STUDY; ENZYME KINETICS; ENZYME PHOSPHORYLATION; HUMAN; HUMAN CELL; MEDIATOR RELEASE; NORMAL HUMAN; PRIORITY JOURNAL; SIGNAL TRANSDUCTION;

EID: 0034654299     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.164.6.3026     Document Type: Article

References (41)

1. MacGlashan, D. W., Jr., S. P. Peters, J. Warner, and L. M. Lichtenstein. 1986. Characteristics of human basophil sulfidopeptide leukotriene release: releasability defined as the ability of the basophil to respond to dimeric cross-links. J. Immunol. 136:2231.
2. Warner, J. A., S. P. Peters, L. M. Lichtenstein, W. Hubbard, K. B. Yancey, H. C. Stevenson, P. J. Miller, and D. W. MacGlashan, Jr. 1989. Differential release of mediators from human basophils: differences in arachidonic acid metabolism following activation by unrelated stimuli. J. Leukocyte Biol. 45:558.
3. Hirai, K., Y. Morita, Y. Misaki, K. Ohta, S. Suzuki, K. Motoyoshi, and T. Miyamoto. 1988. Modulation of human basophil histamine release by hematopoietic growth factors. J. Immunol. 141:3957.
4. Bischoff, S. C., T. Brunner, W. A. L. De, and C. A. Dahinden. 1990. Interleukin 5 modifies histamine release and leukotriene generation by human basophils in response to diverse agonists. J. Exp. Med. 172:1577.
5. Lie, W. J., F. P. Mul, D. Roos, A. J. Verhoeven, and E. F. Knol. 1998. Degranulation of human basophils by picomolar concentrations of IL-3, IL-5, or granulocyte-macrophage colony-stimulating factor. J. Allergy Clin. Immunol. 101: 683.
6. Robinson, D. S., Q. Hamid, S. Ying, A. Tsicopoulos, J. Barkans, A. M. Bentley, C. Corrigan, S. R. Durham, and A. B. Kay. 1992. Predominant TH2-like bronchoalveolar T-lymphocyte population in atopic asthma. N. Engl. J. Med. 326:298.
7. Sedgwick, J. B., W. J. Calhoun, G. J. Gleich, H. Kita, J. S. Abrams. L. B. Schwartz, B. Volovitz, M. Ben-Yaakov, and W. W. Busse. 1991. Immediate and late airway response of allergic rhinilis patients to segmental antigen challenge: characterization of eosinophil and mast cell mediators. Am. Rev. Respir. Dis. 144:1274.
8. Massey, W., B. Friedman, M. Kato, P. Cooper, A. Kagey-Sobotka, L. M. Lichtenstein, and R. P. Schleimer. 1993. Appearance of granulocyte-macrophage colony-stimulating factor activity at allergen-challenged cutaneous late-phase reaction sites. J. Immunol. 150:1084.
9. Kato, M., M. C. Liu, B. A. Stealey, B. Friedman, L. M. Lichtenstein, S. Permutt, and R. P. Schleimer. 1992. Production of granulocyte/macrophage colony-stimulating factor in human airways during allergen-induced late-phase reactions in atopic subjects. Lymphokine Cytokine Res. 11:287.
10. Humbert, M., S. Ying, C. Corrigan, G. Menz, J. Barkans, R. Pfister, Q. Meng, J. Van Damme, G. Opdenakker, S. R. Durham, et al. 1997. Bronchial mucosal expression of the genes encoding chemokines RANTES and MCP-3 in symptomatic atopic and nonatopic asthmatics: relationship to the eosinophil-active cytokines interleukin (IL)-5, granulocyte macrophage-colony-stimulating factor, and IL-3. Am. J. Respir. Cell Mol. Biol. 16:1.
11. MacGlashan, D. W., Jr., and J. A. Warner. 1991. Stimulus-dependent leukotriene release from human basophils: a comparative study of C5a and Fmet-leu-phe. J. Leukocyte Biol. 49:29.
12. MacGlashan, D. W., Jr., and W. C. Hubbard. 1993. Interleukin-3 alters free arachidonic acid generation in C5a-stimulated human basophils. J. Immunol. 151: 6358.
13. Kurimoto, Y., A. L. de Weck, and C. A. Dahinden. 1989. Interleukin 3-dependent mediator release in basophils triggered by C5a. J. Exp. Med. 170:467.
14. 4 release in human basophils. J. Allergy Clin. Immunol. 102:512.
15. 4 generation, but not histamine release nor interleukin-4 (IL-4) production from human basophils. J. Immunol. 162:4198.
16. 2. J. Lipid Mediators Cell Signal. 12:83.
17. 2, a regulatory Ca-dependent lipid binding domain and a Ca-independent catalytic domain. J. Biol. Chem. 269:18239.
18. 2 is phosphorylated and activated by MAP kinase. Cell 72:269.
19. MacGlashan, D. W., Jr., J. M. White, S. K. Huang, S. J. Ono, J. Schroeder, and L. M. Lichtenstein. 1994. Secretion of interleukin-4 from human basophils: the relationship between IL-4 mRNA and protein in resting and stimulated basophils. J. Immunol. 152:3006.
20. Miura, K., and D. W. MacGlashan, Jr. 1998. Expression of protein kinase C isozymes in human basophils: regulation by physiological and nonphysiological stimuli. Blood 92:1206.
21. Gilbert, H. S., and L. Ornstein. 1975. Basophil counting with a new staining method using alcian blue. Blood 46:279.
22. Dumont, F. J., M. J. Staruch, P. Fischer, C. DaSilva, and R. Camacho. 1998. Inhibition of T cell activation by pharmacologic disruption of the MEK1/ERK MAP kinase or calcineurin signaling pathways results in differential modulation of cytokine production. J. Immunol. 160:2579.
23. Offermanns, S., S. V. P. Jones, E. Bombien, and G. Schultz. 1994. Stimulation of mitogen-activated protein kinase activity by different secretory stimuli in rat basophilic leukemia cells. J. Immunol. 152:250.
24. Zhang, C., N. Hirasawa, and M. A. Beaven. 1997. Antigen activation of mitogen-activated protein kinase in mast cells through protein kinase C-dependent and independent pathways. J. Immunol. 1997:4968.
25. 2+ changes in human lung mast cells: graded vs. all-or-nothing elevations after IgE-mediated stimulation. J. Cell Biol. 109:123.
26. Hayes, E. C., D. L. Lombardo, and Y. Girard. 1983. Measuring leukotrienes of slow-reacting substance of anaphylaxis: development of a specific radioimmunoassay. J. Immunol. 131:429.
27. Schroeder, J. T., D. W. MacGlashan, Jr., A. Kagey-Sobotka, J. M. White, and L. M. Lichtenstein. 1994. The IgE-dependent IL-4 secretion by human basophils: the relationship between cytokine production and histamine release in mixed leukocyte cultures. J. Immunol. 153:1808.
28. Siraganian, R. P. 1974. An automated continuous-flow system for the extraction and fluorometric analysis of histamine. Anal. Biochem. 57:383.
29. Schroeder, J. T., D. W. MacGlashan, Jr., A. Kagey-Sobotka, J. M. White, and L. M. Lichtenstein. 1994. IgE-dependent IL-4 secretion by human basophils: the relationship between cytokine production and histamine release in mixed leukocyte cultures. J. Immunol. 153:1808.
30. Alessi, D. R., A. Cuenda, P. Cohen, D. T. Dudley, and A. R. Saltiel. 1996. PD98059 is a specific inhibitor of the activation of mitogen-activated protein kinase kinase in vitro and in vivo. J. Biol. Chem. 270:27489.
31. Zhang, C., R. U. Baumgartner, K. Yamada, and M. A. Beaven. 1997. Mitogen-activated protein (MAP) kinase regulates production of tumor necrosis factor-a and release of arachidonic acid in mast cells: identification of communication between p38 and p42 MAP kinases. J. Biol. Chem. 270:27395.
32. 2, in CD16-triggered granule exocytosis. J. Immunol. 158:3148.
33. Pillay, T. S., S. Xiao, and J. M. Olefsky. 1996. Glucose-induced phosphorylation of the insulin receptor: functional effects and characterization of phosphorylation sites. J. Clin. Invest. 97:613.
34. Rose, D. M., B. W. Winston, E. D. Chan, D. W. Riches, P. Gerwins, G. L. Johnson, and P. M. Henson. 1997. Fcγ receptor cross-linking activates p42, p38, and JNK/SAPK mitogen-activated protein kinases in murine macrophages: role for p42 MAPK in Fcγ receptor-stimulated TNF-α synthesis. J. Immunol. 158:3433.
35. Downey, G. P., J. R. Butler, H. Tapper, L. Fialkow, A. R. Saltiel, B. B. Rubin, and S. Grinstein. 1998. Importance of MEK in human neutrophil microbicidal responsiveness. J. Immunol. 160:434.
36. 2+ for membrane binding but not for catalytic activity. Biochem. Biophys. Res. Commun. 184:118.
37. 2. J. Biol. Chem 274:5163.
38. Warner, J. A., K. B. Yancey, and D. W. MacGlashan, Jr. 1987. The effect of pertussis toxin on mediator release from human basophils. J. Immunol. 139:161.
39. 2 by basic fibroblast growth factor via a p42 mitogen-activated kinase-dependent phosphorylation pathway in endothelial cells. J. Biol. Chem. 270:2360.
40. 2 by p42 microtubule protein 2 kinase and protein kinase C. J. Biol. Chem. 268:1960.
41. 2+ responses in human hasophils: evidence that the initial transient elevation associated with mobilization of intracellular calcium is an insufficient signal for degranulation. J. Immunol. 150:980.